CLINICAL_TRIALS
trial_result
· 2026-08-18
Clinical Trial Update: A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer [Phase 3]
Summary
Phase 3 trial update for CS1001 in stage IV non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CStone Pharmaceuticals | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED